Clinical trial
Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or…
NCT00025519 · Fox Chase Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00025519 |
|---|---|
| Title | Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer |
| Official title | Submyeloablative Allogeneic Blood Stem Cell Transplantation With HLA Identical Donor Lymphocyte Infusions From Matched Related and Matched Unrelated Donors for Treatment of Metastatic Renal Cell Carcinoma |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | therapeutic allogeneic lymphocytes, fludarabine phosphate, mycophenolate mofetil, tacrolimus, thalidomide, peripheral blood stem cell transplantation, radiation therapy |
| Enrollment | 0 |
| Start date | Jun 1, 2001 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 11, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: